These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15129426)

  • 21. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
    Wang W; Bergh A; Damber JE
    Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
    Perry AS; Loftus B; Moroose R; Lynch TH; Hollywood D; Watson RW; Woodson K; Lawler M
    Br J Cancer; 2007 May; 96(10):1587-94. PubMed ID: 17453001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone morphogenic factor gene dosage abnormalities in prostatic intraepithelial neoplasia and prostate cancer.
    Doak SH; Jenkins SA; Hurle RA; Varma M; Hawizy A; Kynaston HG; Parry JM
    Cancer Genet Cytogenet; 2007 Jul; 176(2):161-5. PubMed ID: 17656261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
    Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
    Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
    Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
    In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
    Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA
    Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
    Cheung PK; Woolcock B; Adomat H; Sutcliffe M; Bainbridge TC; Jones EC; Webber D; Kinahan T; Sadar M; Gleave ME; Vielkind J
    Cancer Res; 2004 Sep; 64(17):5929-33. PubMed ID: 15342369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness.
    Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F
    J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
    Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
    Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium.
    Huang J; Powell WC; Khodavirdi AC; Wu J; Makita T; Cardiff RD; Cohen MB; Sucov HM; Roy-Burman P
    Cancer Res; 2002 Aug; 62(16):4812-9. PubMed ID: 12183441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
    Meiers I; Shanks JH; Bostwick DG
    Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.